Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on August 16, 2010, by Lexaria Corp. (Nevada), a company headquartered in Vancouver, British Columbia. The report discloses material events occurring on August 16, 2010, including the granting of stock options and the resumption of field operations at the Belmont Lake Oil Field.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, margin, debt, or liquidity figures. The report focuses on corporate actions and operational updates rather than financial performance data.
Material Changes and Operational Updates
- Stock Option Grant: Under the 2010 Stock Option Plan, the Company granted 150,000 stock options to a consultant. The exercise price is $0.20 per share. Half of the options (75,000) vested immediately, while the remaining 75,000 vest on August 16, 2011. All options expire on August 16, 2015.
- Operational Resumption: Field operations at and near the Belmont Lake Oil Field have recommenced. This follows a seasonal delay caused by abnormally high water levels in the Mississippi River system. Several initiatives are now underway or scheduled to begin.
Guidance, Outlook, and Risks
Management indicated that the resumption of operations allows for the initiation of new projects. The filing notes that the previous delay was due to environmental conditions (high water levels). No specific financial guidance or forward-looking revenue projections were included in this report.
Key Facts for Investor Verification
- Verify the impact of the 150,000 option grant on potential share dilution.
- Confirm the current status and production output of the Belmont Lake Oil Field following the resumption of operations.
- Review the terms of the 2010 Stock Option Plan to understand the full scope of equity compensation.
- Monitor for subsequent filings regarding the specific initiatives mentioned as "underway or soon to begin."